S&P 500
(-0.41%) 5 460.48 points
Dow Jones
(-0.12%) 39 119 points
Nasdaq
(-0.71%) 17 733 points
Oil
(-0.34%) $81.46
Gas
(-3.13%) $2.60
Gold
(0.01%) $2 336.90
Silver
(0.61%) $29.44
Platinum
(0.28%) $1 009.00
USD/EUR
(-0.06%) $0.933
USD/NOK
(0.45%) $10.68
USD/GBP
(-0.05%) $0.791
USD/RUB
(0.86%) $85.73

リアルタイムの更新: Lifecore Biomedical, Inc. [LFCR]

取引所: NASDAQ セクター: Healthcare 産業: Drug Manufacturers - Specialty & Generic
最終更新日時29 6月 2024 @ 05:00

-0.19% $ 5.13

Live Chart Being Loaded With Signals

Commentary (29 6月 2024 @ 05:00):
Our systems believe the stock currently is undervalued by 0.56% compare to its pairs and should correct upwards.

Lifecore Biomedical, Inc., together with its subsidiaries, operates as an integrated contract development and manufacturing organization in the United States and internationally...

Stats
本日の出来高 2.26M
平均出来高 189 433
時価総額 156.71M
EPS $-1.190 ( Q4 | 2024-03-20 )
次の収益日 ( $-0.260 ) 2024-08-29
Last Dividend $0 ( N/A )
Next Dividend $0 ( N/A )
P/E -2.40
(Sector) 42.63
(Industry) 30.78
ATR14 $0.0130 (0.25%)
AERI 0.00%
ALVO 1.33%
ALVOW 6.79%
BDSI -0.09%
BFRIW -5.93%
CLVRW 0.00%
CYTHW -4.35%
ENDP 0.00%
GRVI 7.61%
HPCO 0.06%
INDV -1.59%
JUPWW -20.00%
LFCR -0.19%
LNDC -3.52%
LSDI -23.29%
PRFX -3.65%
PROCW 10.09%
QLI 6.82%
SBFMW 0.00%
SHOT 9.43%
SHPH 4.28%
Insider Trading
Date Person Action Amount type
2024-05-20 Josephs Paul Buy 525 000 Common Stock
2024-05-20 Josephs Paul Sell 8 975 Common Stock
2024-05-20 Josephs Paul Buy 1 500 000 Performance-Based Restricted Stock Units
2024-05-20 Josephs Paul Sell 0 No Security beneficially owned
2024-02-01 Schechter Joshua Buy 9 554 Common Stock
INSIDER POWER
91.35
Last 68 transactions
Buy: 3 346 123 | Sell: 159 581
相関 (AI algo v.1.1b): Undervalued: 0.56% $5.19 paired level. (アルゴリズムは、最も相関の高い株式の変更をリアルタイムで追跡し、即時の更新を提供します)

ボリューム 相関

長: -0.24 (neutral)
短: 0.76 (moderate)
Signal:(48.939) Neutral

Lifecore Biomedical, Inc. 相関

10 最も正の相関
10 最も負の相関

知っていましたか?

相関は、2つの変数間の関係を説明する統計的指標です。相関係数は-1から1までの値を取り、-1は完全な負の相関(1つの変数が増加すると、もう一方は減少する)、1は完全な正の相関(1つの変数が増加すると、もう一方も増加する)、0は相関がないことを示します(変数間に関係がない)。

相関は、株式だけでなく、どの2つの変数間の関係にも適用できます。これは、金融、経済学、心理学などの分野で一般的に使用されています。

Lifecore Biomedical, Inc. 相関 - 通貨/商品

The country flag 0.07
( neutral )
The country flag -0.24
( neutral )
The country flag 0.00
( neutral )
The country flag 0.00
( neutral )
The country flag 0.00
( neutral )
The country flag -0.34
( neutral )

Lifecore Biomedical, Inc. 財務諸表

Annual 2023
収益: $103.27M
総利益: $27.29M (26.43 %)
EPS: $-3.41
FY 2023
収益: $103.27M
総利益: $27.29M (26.43 %)
EPS: $-3.41
FY 2023
収益: $103.27M
総利益: $27.29M (26.43 %)
EPS: $-3.41
FY 2022
収益: $185.79M
総利益: $50.37M (27.11 %)
EPS: $-3.29

Financial Reports:

No articles found.

Lifecore Biomedical, Inc. Options Data

Calls

Contract Name Last Trade Date (EDT) Strike Last Price Bid Ask Change % Change Volume Open Interest Implied Volatility Strike Date
No data available

Puts

Contract Name Last Trade Date (EDT) Strike Last Price Bid Ask Change % Change Volume Open Interest Implied Volatility Strike Date
No data available

Lifecore Biomedical, Inc.

Lifecore Biomedical, Inc., together with its subsidiaries, operates as an integrated contract development and manufacturing organization in the United States and internationally. It operates through Lifecore, Curation Foods, and Other segments. The Lifecore segment engages in the manufacture of pharmaceutical-grade sodium hyaluronate (HA) in bulk form, as well as formulated and filled syringes and vials for injectable products used in treating a range of medical conditions and procedures. It also provides services, including technology development, material component changes, analytical method development, formulation development, pilot studies, stability studies, process validation, and production of materials for clinical studies to its partners for HA-based and non-HA based aseptically formulated and filled products. This segment sells its non-HA products for medical use primarily in the ophthalmic, orthopedic, and other markets. The Curation Foods segment engages in processing, marketing, and selling of olive oils and wine vinegars under the O brand; and guacamole and avocado food products under the Yucatan and Cabo Fresh brands, as well as various private labels. The company was formerly known as Landec Corporation and changed its name to Lifecore Biomedical, Inc. in November 2022. Lifecore Biomedical, Inc. was incorporated in 1986 and is headquartered in Santa Maria, California.

について ライブシグナル

このページで提示されるライブシグナルは、NA を買う時や売る時を判断するのに役立ちます。シグナルには1分以上の遅延があります。市場シグナルには誤りやミスの可能性があるため、ライブ取引シグナルは決定的ではなく、getagraph.comはこれらのシグナルに基づく任意の行動について責任を負いません。詳細については、利用規約で説明されているように、技術分析指標に基づいています。

Total Execution Time: 1.3977949619293 seconds
Number of API calls: 3
Number of DB calls: 9